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ABSTRACT
Objective: To assess the results of physical therapy management and surgical treatment in a prospective observational
cohort of patients with neurogenic thoracic outlet syndrome (NTOS) using patient-reported outcomes measures.
Methods: Of 183 new patient referrals from July 1 to December 31, 2015, 150 (82%) met the established clinical diagnostic
criteria for NTOS. All patients underwent an initial 6-week physical therapy trial. Those with symptom improvement
continued physical therapy, and the remainder underwent surgery (supraclavicular decompression with or without
pectoralis minor tenotomy). Pretreatment factors and 7 patient-reported outcomes measures were compared between
the physical therapy and surgery groups using t-tests and c2 analyses. Follow-up results were assessed by changes in
11-item version of Disability of the Arm, Shoulder, and Hand (QuickDASH) scores and patient-rated outcomes.
Results: Of the 150 patients, 20 (13%) declined further treatment or follow-up, 40 (27%) obtained satisfactory improve-
ment with physical therapy alone, and 90 (60%) underwent surgery. Slight differences were found between the physical
therapy and surgery groups in the mean 6 standard error degree of local tenderness to palpation (1.7 6 0.1 vs 2.0 6 0.1;
P ¼ .032), the number of positive clinical diagnostic criteria (9.0 6 0.3 vs 10.1 6 0.1; P ¼ .001), Cervical-Brachial Symptom
Questionnaire scores (68.06 4.1 vs 78.0 6 2.7; P ¼ .045), and Short-Form 12-item physical quality-of-life scores (35.6 6 1.5 vs
32.0 6 0.8; P ¼ .019) but not other pretreatment factors. During follow-up (median, 21.1 months for physical therapy and
12.0 months for surgery), the mean change in QuickDASH scores for physical therapy was 15.6 6 3.0 (29.5% 6 5.7%)
compared with 29.8 6 2.4 (47.9% 6 3.6%) for surgery (P ¼ .001). The patient-rated outcomes for surgery were excellent
for 27%, good for 36%, fair for 26%, and poor for 11%, with a strong correlation between the percentage of decline in the
QuickDASH score and patient-rated outcomes (P < .0001).
Conclusions: The present study has demonstrated contemporary outcomes for physical therapy and surgery in a well-
studied cohort of patients with NTOS, reinforcing that surgery can be effective when physical therapy is insufficient,
even with substantial pretreatment disability. Substantial symptom improvement can be expected forw90% of patients
after surgery for NTOS, with treatment outcomes accurately reflected by changes in QuickDASH scores. Within this
cohort, it was difficult to identify specific predictive factors for individuals most likely to benefit from physical therapy
alone vs surgery. (J Vasc Surg 2019;70:832-41.)
Keywords: Brachial plexus; Chronic pain; Compression neuropathy; Depression; Disability; Patient-reported outcomes
measures; Pain catastrophizing; Physical therapy; Quality of life; Surgical treatment; Thoracic outlet syndrome
Neurogenic thoracic outlet syndrome (NTOS) is a rela-
tively rare, complicated, and, at times, controversial
condition characterized by dynamic positional
compression of the brachial plexus at the level of the
supraclavicular scalene triangle or the subcoracoid
(pectoralis minor) space.1-3 Some of the longstanding,
but unresolved, questions about NTOS have involved
the most appropriate criteria for the diagnosis, accurate
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assessment and reporting of treatment results, and
approaches to better predict individual patient out-
comes for various treatment options.1-5 During the
past decade, the Consortium for Research and Educa-
tion on Thoracic Outlet Syndrome (CORE-TOS) sought
to address the question of diagnostic standards, using
a Delphi approach to develop a set of consensus-
based clinical diagnostic criteria (CDC) for NTOS.6,7
Our group, and others, has also attempted to establish
more accurate methods to quantify the disability and
assess the treatment results in patients with NTOS
using patient-reported outcomes measures (PROMs)
for different, but related, domains, such as pain, func-
tional disability, depression, physical and mental quality
of life (QOL), and pain catastrophizing.7-19
In a recent report, we described a prospective observa-
tional cohort study in which the relative strengths of the
14 CORE-TOS CDC and 7 PROMs were examined in
patients with suspected NTOS.7 The results helped vali-
date the utility of the CDC used for evaluation of NTOS
and demonstrated strong correlations between PROMs
covering different domains of symptomatic disability.
The purpose of the present study was to extend our anal-
ysis of this prospective cohort to compare the results of
physical therapy management and surgical treatment
during follow-up using both PROMs and patient-rated
outcomes and to evaluate the potential associations
between the clinical features at initial presentation and
treatment outcomes.
METHODS
Study population and clinical diagnosis. All the sub-
jects in the present study gave written informed consent
for the report of their medical data through a protocol
approved by the human research protection office at
Washington University (St. Louis, Mo). The initial study
population consisted of all new patients referred to the
Washington University Center for Thoracic Outlet Syn-
drome at Barnes Jewish Hospital from July 1 to
December 31, 2015. Data collected from office notes, hos-
pital records, imaging studies, and records from the
treating physicians and therapists were entered into a
prospectively maintained database. Of the 183 newly
referred patients, 150 (82%) had met the predefined
CORE-TOS CDC for NTOS, as reported previously.7 Each
patient had also met the diagnostic criteria for NTOS
described in the 2016 reporting standards of the Society
for Vascular Surgery.2 The results from the imaging
studies and electrophysiological tests were not consid-
ered necessary to establish a clinical diagnosis of NTOS
but were used for selected patients to help assess or
exclude other conditions. Ultrasound-guided local
anesthetic anterior scalene and pectoralis minor muscle
blocks were also used selectively to identify variations
in anatomy and, potentially, provide prognostic infor-
mation.20-22 The 150 patients with a verified diagnosis of
NTOS represented the starting patient population for the
present study (Fig 1).
Treatment algorithm. All patients with NTOS under-
went a physical therapy evaluation and treatment guided
by 1 of 3 physical therapists alignedwith our TOS Center at
The Rehabilitation Institute of St. Louis. The physical
Fig 1. Schematic flow diagram for a prospective observa-
tional cohort of patients with neurogenic thoracic outlet
syndrome (NTOS). Dx, Diagnostic.
ARTICLE HIGHLIGHTS
d Type of Research: Retrospective cohort study of pro-
spectively collected data
d Key Findings: During a median follow-up
>12 months of 130 patients with neurogenic thoracic
outlet syndrome, 40 (31%) obtained symptom
improvement with physical therapy alone and 90
(69%) underwent surgery, with a percentage of
decline in Disability of the Arm, Shoulder, and
Hand scores of 29.5% 6 5.7% and 47.9% 6 3.6%,
respectively.
d Take Home Message: Despite substantial pretreat-
ment disability, surgery for neurogenic thoracic
outlet syndrome can be effective when physical ther-
apy is insufficient, with substantial symptom
improvement in w90% of patients. These outcomes
were reflected by changes in Disability of the Arm,
Shoulder, and Hand scores, but no specific factors
predicted which patients will benefit from physical
therapy alone or will require surgery.
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therapyprogramconsistedof scalene andpectoralismus-
cle stretching and relaxing exercises, with a focus on
shoulder girdle and scapular mobility, mechanics,
postural improvement, and diaphragmatic breathing, us-
ing caution with strengthening, weight training, and the
use of resistance bands.23-27 For patients residing at a
distance from St. Louis, the physical therapy trial was
implemented by a therapist located closer to the patient,
with guidance, oversight, and follow-up assessment pro-
vided by the TOS Center therapist. Physical therapy was
conducted for 4 to 6 weeks, unless the patient had previ-
ously undergonephysical therapy consideredappropriate
Table I. Patient characteristics at presentation
Characteristic Physical therapy alone (n ¼ 40) Surgical treatment (n ¼ 90) P value
Age, years 37.7 6 2.3 36.9 6 1.4 .759a
Female gender 29 (72) 66 (73) 1.000b
NTOS
Bilateral 11 (27) 21 (23) .661b
Recurrent 1 (2) 9 (9) .174b
Symptom duration
3-6 months 6 (15) 11 (12) .779b
6-12 months 8 (20) 14 (16) .614b
1-2 years 5 (12) 12 (13) 1.00b
2-5 years 13 (32) 21 (24) .287b
>5 years 8 (20) 32 (35) 1.00b
>2 years 21 (52) 53 (59) .566b
Previous injury
None 11 (27) 16 (18) .244b
Accidental 7 (17) 18 (20) .814b
Recreational 13 (32) 24 (27) .531b
Occupational 9 (22) 32 (35) .157b
All types 29 (72) 74 (82) .244b
Degree of tendernessc 1.7 6 0.1 2.0 6 0.1 .032a
Subcoracoid findings only 2 (5) 4 (4) 1.00b
3-Minute EAST, seconds 103.0 6 10.2 97.0 6 6.3 .610a
Positive CDC,c n 9.0 6 0.3 10.1 6 0.1 .001a
QuickDASH score 52.9 6 3.4 60.3 6 2.1 .058a
CBSQc 68.0 6 4.1 78.0 6 2.7 .045a
McGill pain score 29.4 6 2.1 29.6 6 1.1 .928a
BPI
Severity 4.9 6 0.3 5.0 6 0.2 .785a
Interference 5.2 6 0.4 5.4 6 0.2 .616a
Zung SDS score 42.5 6 1.6 43.0 6 1.0 .774a
SF-12 physical QOLc 35.6 6 1.5 32.0 6 0.8 .019a
SF-12 mental QOL 46.1 6 1.8 47.8 6 1.1 .423a
PCS score
Overall 24.9 6 2.3 24.5 6 1.5 .864a
Rumination 9.1 6 0.8 8.7 6 0.5 .679a
Magnification 3.9 6 0.6 4.4 6 0.3 .459a
Helplessness 12.0 6 1.2 11.4 6 0.7 .651a
BPI, Brief Pain Inventory; CBSQ, Cervical-Brachial Symptom Questionnaire; CDC, clinical diagnostic criteria; EAST, elevated arm stress test; NTOS,
neurogenic thoracic outlet syndrome; PCS, Pain Catastrophizing Scale; QOL, quality of life; QuickDASH, 11-item version of the Disabilities of the Arm,
Shoulder, and Hand; SDS, Self-rating Depression Scale; SF-12, Short-Form, 12-item questionnaire.
Data are presented as mean 6 standard error for continuous measures and number of patients (%) for categorical variables. Of the 150 patients, 20
(13%) declined further treatment or follow-up, leaving 130 for assessment of physical therapy management alone (n ¼ 40) or surgical treatment
(n ¼ 90).
aUnpaired t-test.
bFisher’s exact test.
cP < .05.
834 Balderman et al Journal of Vascular Surgery
September 2019
by the TOS Center therapist or if their symptoms had
worsened during the initial therapy visits, in which case,
earlier consideration was given for surgical treatment.
During the office follow-up visit and reassessment,
patients who experienced an improvement in symptoms
during the initial course of physical therapy were encour-
aged to continue with physical therapy. Surgery was
offered to patients who had a sound clinical diagnosis
of NTOS, a significant level of disability, and insufficient
improvement in symptoms with physical therapy, as
determined by the assessment of the physician, thera-
pist, and patient.
Surgical treatment. Throughout the study period, sur-
gery for NTOS consisted of supraclavicular decompres-
sion (with complete anterior and middle scalenectomy,
first rib resection, and brachial plexus neurolysis) or sub-
coracoid decompression (pectoralis minor tenotomy),
or both, as previously described in detail.28-30 The site of
operative decompression was determined for each
patient from the clinical examination findings at the level
of the scalene triangle or subcoracoid space, as
previously described.13 Postoperative complications,
hospital stay, and readmissions were all recorded in the
prospective database. The surgery patients resumed
physical therapy 3 to 4 weeks postoperatively, preferably
with the same TOS Center therapist with whom they had
worked during the initial physical therapy trial.
Follow-up and patient-reported outcomes measures.
The patients were seen for office visits every 3 to 4months
after the start of treatment, and more frequently when
necessary. At each visit, the patients were asked to com-
plete the Disabilities of the Arm, Shoulder and Hand
(QuickDASH) survey instrument, Cervical-Brachial
Symptom Questionnaire (CBSQ), McGill pain question-
naire (McGill), Brief Pain Inventory, Zung self-rating
depression scale, Short-Form, 12-item physical and
mental summary scales (SF-12), and pain catastrophizing
scale (PCS), as previously described.7 The patients who
had undergone surgery were also asked to rate their
treatment outcome using a simple scale with the
descriptors “excellent” (relief of almost all major symp-
toms with only some mild residual symptoms that do
not significantly limit enjoyment of life), “good” (relief of
most major symptoms with some mild residual symp-
toms that significantly limit enjoyment of life), “fair”
(partial relief of some symptoms while other major
symptoms persist), or “poor” (not enough relief in symp-
toms to have made the operation worthwhile).
Statistical analysis. The principal outcomes measure
was the percentage of improvement in the QuickDASH
score between the initial evaluation and the longest
follow-up interval. Descriptive data are presented as the
mean 6 standard error or the median and range. For the
2-group comparisons, a c2 analysis or the unpaired Stu-
dent t-test with a 2-tailed distribution were used to
determine statistical significance. For multiple-group
comparisons, the Kruskal-Wallis nonparametric analysis
of variance (ANOVA) test was used with the Dunn mul-
tiple comparisons test. In selected instances, Spearman
correlation tests were performed with calculation of the
r and R2 values. Receiver operating characteristic curves
were constructed to assess a cutoff point for change in
QuickDASH scores that corresponded to positive patient-
rated outcomes. The cutoff point was calculated on the
basis of the best trade-off value between sensitivity and
specificity. Multivariate logistic regression analysis was
performed with calculation of the odds ratios to predict
the optimal change in the QuickDASH scores. All statis-
tical tests were performed using Prism, version 6.0h
(GraphPad Software Inc, San Diego, Calif), with P < .05
considered statistically significant.
RESULTS
Outcomes of initial physical therapy trial. Of the initial
cohort of 150 patients meeting the CDC for NTOS, 20
(13%) declined further treatment or follow-up (Fig 1). Of
Fig 2. Treatment outcomes after physical therapy or sur-
gery for neurogenic thoracic outlet syndrome (NTOS). A,
Bar graphs depicting Disability of the Arm, Shoulder, and
Hand (QuickDASH) scores before and during follow-up
after physical therapy and surgical treatment. Two-group
comparisons were performed using the unpaired t-test.
B, Bar graph depicting the response to treatment
measured by the percentage of improvement in Quick-
DASH scores and patient-rated outcomes for surgical
treatment. Multiple-group comparison was performed
using the Kruskal-Wallis analysis of variance. SEM, Stan-
dard error of the mean.
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the remaining 130 patients, 40 (27%) obtained satisfac-
tory symptom improvement with the initial physical
therapy trial and chose to continue conservative man-
agement. Finally, 90 patients (60%) experienced insuffi-
cient improvement with physical therapy and
subsequently elected to undergo surgery.
No differences were found in the presenting character-
istics between the physical therapy and surgery groups
in age, gender, symptom duration, previous injury, pain-
related PROM scores, pain catastrophizing scores, or
frequency of positive scalene muscle blocks (Table I).
The mean degree of local tenderness to palpation, total
number of positive CDC, and CBSQ scores were lower
for the physical therapy group than for the surgery group,
and the SF-12 physical QOL scores were lower in the sur-
gery group. The pretreatment QuickDASH scores were
not significantly different between the 2 groups.
Surgical treatment. In the surgical treatment group, 20
patients (22.2%) had presented with bilateral NTOS, 4
(4.4%) with a cervical rib, and 7 (7.8%) with recurrent
NTOS after having undergone a previous procedure at
another institution. The mean interval between the initial
office visit and surgery was 115 6 11 days. The operations
performed included supraclavicular decompression
and ipsilateral pectoralis minor tenotomy in 70 patients
(77.8%), supraclavicular decompression and bilateral
pectoralis minor tenotomy in 12 (13.3%), supraclavicular
decompression alone in 4 (4.4%), and isolated pectoralis
minor tenotomy in 4 patients (4.4%). No intraoperative
complications developed; however, five patients (5.5%)
experienced prolonged lymph drainage that required
medical management (low-fat diet and octreotide). The
mean hospital stay was 4.3 6 0.2 days and four patients
(4.4%) required readmission within 30 days (1 each for
subclavian vein thrombosis, thoracic duct embolization,
drainage of a superficial wound infection, and excision
of a stitch granuloma).
Follow-up and treatment outcomes. The mean follow-
up interval was 20.4 6 0.8 months for the physical ther-
apy group and 12.3 6 0.7 months postoperatively for the
surgery group. The mean follow-up QuickDASH score for
the physical therapy group was 37.26 3.9 compared with
52.9 6 3.4 at the initial presentation, with a mean decline
in the QuickDASH score of 15.6 6 3.0 (29.5% 6 5.7%;
P < .0001; Fig 2, A). For the surgical treatment group, the
mean follow-up QuickDASH score was 30.4 6 2.3
compared with 60.3 6 2.1 at the initial presentation, with
a mean decline in the QuickDASH score of 29.8 6 2.4
(47.9% 6 3.6%; P < .0001). Although significant
improvement was seen in both groups, the percentage
of improvement in the QuickDASH scores was greater for
the surgery group than for the physical therapy group
Table II. Response to treatment stratified by surgical procedure
Variable Patients, No.
Initial assessment
(QuickDASH)
Follow-up assessments
QuickDASH Delta DASH Change, %
SCD, ipsilateral PMT 70 62.6 6 2.2 27.7 6 2.5 34.5 6 2.8 55.2 6 3.6a
SCD, bilateral PMT 12 61.7 6 4.3 42.5 6 6.4 20.7 6 4.6 34.2 6 7.5
SCD alone 4 39.5 6 16.0 11.3 6 7.3 17.8 6 10.1 41.8 6 21.0
PMT alone 4 36.9 6 12.2 30.5 6 12.3 6.4 6 6.5 þ4.6 6 35.2a
PMT, Pectoralis minor tenotomy; QuickDASH, 11-item version of the Disabilities of the Arm, Shoulder, and Hand; SCD, supraclavicular decompression.
Data are presented as mean 6 standard error.
aP ¼ .002, 1-way analysis of variance with Tukey’s multiple comparisons test.
Fig 3. Influence of patient age on outcomes of surgical
treatment for neurogenic thoracic outlet syndrome
(NTOS). A, Scatter plot illustrating the relationship
between patient age and response to surgical treatment,
measured by the percentage of improvement in Disability
of the Arm, Shoulder, and Hand (QuickDASH) scores. B,
Bar graph depicting QuickDASH scores before and during
follow-up after surgical treatment for patients
aged <40 years and $40 years. Two-group comparisons
were performed using the unpaired t-test.
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(P ¼ .001). The results of the outcomes measures were
somewhat different among the patients undergoing
different surgical procedures (P ¼ .002, ANOVA). How-
ever, the number of patients in the isolated pectoralis
minor tenotomy and the supraclavicular decompres-
sion alone groups was too low (n ¼ 4 each), and the
range of outcomes too broad, to permit reliable
between-group comparisons (Table II). The overall
patient-rated outcomes for surgical treatment were
excellent for 27%, good for 36%, fair for 26%, and poor
for 11% of the surgery group, with a strong relationship
between the percentage of decline in the QuickDASH
score and the patient-rated outcomes category
(P < .0001, ANOVA; Fig 2, B).
Determinants of outcomes after surgical treatment.
Based on the results from previous studies, patient age at
the initial presentation was examined as a potential fac-
tor in determining the outcomes of surgery.12,31-33 A sig-
nificant association was found between patient age and
the percentage of improvement in the QuickDASH score
during follow-up (P ¼ .006, Spearman correlation), with
younger patients having better outcomes (Fig 3, A). The
mean follow-up QuickDASH score for patients
aged <40 years (n ¼ 48) was 24.9 6 2.8 compared with
61.0 6 3.0 at the initial presentation, with a mean decline
in the QuickDASH score of 36.2 6 3.5 (55.2% 6 5.4%;
P < .0001; Fig 3, B). Themean follow-up QuickDASH score
for patients age $40 years (n ¼ 42) was 36.7 6 3.5
compared with 59.5 6 2.9 at the initial presentation, with
a mean decline in the QuickDASH score of 22.4 6 3.0
(39.8% 6 4.5%; P < .0001). Although significant
improvement was found in both groups, the percentage
of improvement in the QuickDASH scores for patients
aged <40 years was greater than that for patients aged
$40 years (P ¼ .034).
Previous studies have indicated that positive anterior
scalene and pectoralis minor muscle blocks might pre-
dict better outcomes from surgical treatment for
NTOS.33-35 In the present cohort, muscle blocks were per-
formed as part of the initial pretreatment evaluation for
32 patients (80%) in the physical therapy group and 62
patients (69%) in the surgical treatment group. For the
patients in the physical therapy group with negative
muscle block findings, the mean decline in the Quick-
DASH score was 27.9% 6 18.3% compared with
30.6% 6 7.1% for patients with positive block findings
(P > .05; Table III). These results demonstrate that positive
muscle block findings did not effectively predict the
treatment outcomes for the patients undergoing phys-
ical therapy management alone. For the patients in the
surgical treatment group with negative muscle block
findings, the mean decline in the QuickDASH score was
34.3% 6 10.7% compared with 52.2% 6 4.5% for patients
with positive block findings (P ¼ .092). This finding indi-
cates significant improvement in the surgical group,
regardless of the outcome of the pretreatment muscle
block, with a trend toward a greater percentage of
improvement in the QuickDASH scores for patients
with positive muscle block findings that did not reach
statistical significance.
One of the goals of the present study was to examine
the use of various PROMs measured at the initial patient
presentation to serve as predictors of treatment
outcome, with a particular interest in pain catastrophiz-
ing.7 The mean decline in the QuickDASH score was
28.8 6 2.9 (48.2% 6 4.7%) for patients with low pain cat-
astrophizing at the initial presentation (PCS score <30;
Table III. Influence of muscle block findings on response to treatment stratified by treatment received
Variable Patients, No. Initial assessment (QuickDASH)
Follow-up assessment
QuickDASH Delta DASH Change, %
Physical therapy alone
All patients 40 52.9 6 3.4 37.2 6 3.9 15.6 6 3.0 29.5 6 5.7
No block performed 8 59.5 6 8.4 43.3 6 9.7 16.2 6 6.7 27.1 6 11.3
Block performed 32 51.2 6 3.7 35.7 6 4.3 15.5 6 3.4 30.1 6 6.6
Positive finding 26 53.6 6 4.1 37.4 6 4.9 16.2 6 3.9 30.6 6 7.1a
Negative finding 6 40.7 6 8.3 28.5 6 8.7 12.2 6 7.2 27.9 6 18.3a
Surgical treatment
All patients 90 60.3 6 2.1 30.4 6 2.3 29.8 6 2.4 47.9 6 3.6
No block performed 28 55.8 6 4.2 25.8 6 2.9 30.0 6 4.2 46.2 6 7.1
Block performed 62 62.3 6 2.4 32.4 6 3.0 29.7 6 3.0 48.7 6 4.2
Positive finding 50 62.3 6 2.8 30.3 6 3.3 31.8 6 3.2 52.2 6 4.5b
Negative finding 12 62.3 6 4.1 41.1 6 7.5 21.2 6 7.6 34.3 6 10.7b
QuickDASH, 11-Item version of the Disabilities of the Arm, Shoulder, and Hand questionnaire.
Data are presented as mean 6 standard error.
aP ¼ .875, unpaired t-test.
bP ¼ .092, unpaired t-test.
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65% of patients; Fig 4, A). The mean decline in Quick-
DASH score was 31.26 4.2 (47.56 5.8 percent) for patients
with high pain catastrophizing at initial presentation
(PCS score $30; 35% of patients). Thus, the pretreatment
levels of pain catastrophizing did not have a significant
influence on the surgical treatment outcomes (P > .05).
However, in assessing the potential changes in pain cat-
astrophizing during follow-up, those with favorable
patient-rated outcomes had significant decreases in
the mean PCS scores. In contrast, those with poor
patient-rated outcomes exhibited no change (Fig 4, B).
Multivariate analysis. In attempting to better identify
the predictors of clinical outcomes, the patients who
had undergone surgery were divided into “responders”
(patient-rated outcomes of fair, good, or excellent) and
“nonresponders” (patient-rated outcomes of poor). A
threshold cutoff distinguishing the 2 groups was found
at a percentage of improvement in the QuickDASH score
of 27.4%. Multivariate logistic regression analysis was per-
formed with a spectrum of pretreatment variables, con-
trolling for patient age, gender, and symptom duration
>2 years. The pretreatment SF-12 physical QOL score
was the only variable with predictive value in dis-
tinguishing positive from negative responses to surgery
(odds ratio, 1.12; P ¼ .031; Fig 5).
DISCUSSION
In the present study, we assessed the results of physical
therapy management and surgical treatment for
patients with NTOS using well-defined CDC for NTOS
and a series of PROMs in a prospective, observational
patient cohort. Our results have demonstrated that
even with substantial levels of pretreatment disability,
physical therapy alone was effective in 31% of the patient
cohort that had continued treatment and follow-up. Sur-
gical treatment was effective when physical therapy
alone was insufficient, with substantial symptom
improvement in w90% of patients. We observed that
surgical treatment outcomes were accurately reflected
by changes in the QuickDASH scores measured during
follow-up, reinforcing the validity of this instrument to
quantify the treatment results of patients with NTOS.
We also found no pretreatment factors that allowed for
a sound prediction regarding the individual patients
who might respond sufficiently to physical therapy alone
but that an empirical treatment trial was necessary. For
patients undergoing surgery, other than age at presenta-
tion, CBSQ score, and SF-12 physical QOL score, we could
not identify any specific pretreatment factors or patient
profiles that reliably predicted the outcomes.
The treatment algorithm followed in the present study
is based on long-established clinical practice and experi-
ence in the management of NTOS but differs from the
process described by some investigators. For example,
Chandra et al36 described a “highly selective” algorithm
with all patients undergoing an initial trial of physical
therapy and surgical treatment reserved for those exhib-
iting improvement. This approach appears counterintui-
tive, because some patients with the most disabling
symptoms and the greatest potential for improvement
might not be offered surgical treatment, and at least
some of those with improvement after the initial physical
therapy trial might undergo surgical treatment unneces-
sarily. Thus, we believe the algorithm followed in the pre-
sent study is more aligned with the typical clinical
practice approaches used by most physicians who treat
patients with NTOS.
The physical therapy regimen used throughout the pre-
sent study was specific to NTOS, differing from the phys-
ical therapy approaches typical for other neck and upper
extremity conditions.23-27 This is important to ensure an
adequate trial of conservative management before
considering surgery. We also found that the initial phys-
ical therapy trial was valuable even for patients consid-
ered likely to require surgical treatment, because the
physical therapy trial allowed the therapist to establish
Fig 4. Association between pretreatment pain cata-
strophizing and outcomes of surgical treatment for
neurogenic thoracic outlet syndrome (NTOS). A, Bar graph
depicting Disability of the Arm, Shoulder, and Hand
(QuickDASH) scores before and during follow-up after
surgical treatment for patients with low (Pain Cata-
strophizing Scale [PCS] score <30) and high (PCS score
$30) pain catastrophizing. B, Bar graph depicting changes
in pain catastrophizing after surgical treatment for NTOS
stratified by patient-rated outcomes for surgical treat-
ment. Two-group comparisons were performed using
the unpaired t-test. *P < .01; **P < .0001. NS, Not significant
(P > .05); SEM, standard error of the mean.
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a baseline status for the individual patient, teach NTOS-
specific protocols, help manage expectations for treat-
ment, and better anticipate specific needs that might
arise during postoperative rehabilitation. An integrated
multidisciplinary center has an advantage compared
with practice settings in which NTOS is treated only on
an occasional basis without established protocols.
It is notable that our initial assessment approach did
not include the routine use of anterior scalene and pec-
toralis minor muscle blocks nor were positive findings
from muscle blocks considered necessary before
patients could be considered for surgery. Although
Lum et al,33 Jordan and Machleder,34 and Jordan35
described better outcomes from surgical treatment for
patients with positive findings from pretreatment mus-
cle blocks, we found in our cohort that muscle blocks
did not serve as a statistically significant predictor of
the surgical treatment outcome. The present cohort
was relatively small for rigorous analysis of this question
and we found found a strong trend toward improved
outcomes in patients with positive findings from a mus-
cle block. Thus, we cannot conclude that the findings
from muscle blocks have no predictive value and believe
this question warrants ongoing study.
The assessment of patient disability using well-defined
PROMs represents a quantifiable approach to evaluate
the effectiveness of a treatment. In the present study,
the most useful PROMs for the evaluation of patients
with NTOS appeared to be the QuickDASH, CBSQ,
and SF-12 physical QOL. The use of changes in the
QuickDASH score to assess treatment outcomes has a
distinct advantage, providing an objective measure of
the disability with an instrument widely used for
patients with NTOS and other upper extremity
conditions.7,10-13,15,16,19,36,37 In contrast, PROMs related to
the domain of pain appeared redundant and not as use-
ful in assessing disability, overall functional limitations,
and QOL. Although in our previous study, high pain cat-
astrophizing was evident in 38% of patients with NTOS,
the pretreatment PCS scores did not predict the out-
comes after surgical treatment. This suggests that pain
catastrophizing is more variable than previously consid-
ered and might respond favorably to improvements in
physical symptoms. Our data showed that follow-up
PCS scores decreased significantly in those with favor-
able patient-rated outcomes.38,39 It remains unclear
whether this was simply a consequence of symptom
improvement; however, persistently high pain cata-
strophizing might help identify patients at risk of poor
outcomes. On multivariate analysis of other predictors
of outcome, we found that only the SF-12 physical QOL
score was significantly associated with the response to
surgical treatment. The odds ratio for this association
was nonetheless relatively small, indicating that the
results predicted from this single instrument should
not be considered strong enough to guide treatment
decisions.
Thepresent studyhad several limitations. First, as noted in
our initial study, the patients in our cohort likely exhibited a
greater degree of disability at initial presentation than
might be seen in other practice settings, and patients
with milder degrees of NTOS might have a greater likeli-
hood of satisfactory improvement with physical therapy
alone.7 Our outcomes thereby reflect a dedicated
Fig 5. Forest plot for multivariate logistic regression of pretreatment patient-reported outcomes measures
(PROMs) to predict response to surgical treatment for neurogenic thoracic outlet syndrome (NTOS). Data shown
indicate odds ratios (ORs) and 95% confidence intervals (CIs; in parentheses) for each PROM and corrected for
age, gender, and symptom duration >2 years. BPI, Brief Pain Inventory; CBSQ, Cervical-Brachial Symptom
Questionnaire; PCS, Pain Catastrophizing Scale; SDS, Self-rating Depression Scale; SF-12, Short Form, 12-item
quality of life questionnaire.
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multidisciplinary referral program for the management of
NTOS andmight not translate to practiceswith less experi-
ence with physical therapy or surgical treatment.
One difficulty with the QuickDASH instrument has
been that for patients with bilateral symptoms, the func-
tional improvement after treatment for 1 limb might be
overshadowed by persistent limitations in the contralat-
eral (untreated) limb. The QuickDASH scores can also
vary inconsistently at different follow-up intervals after
treatment. In the present study, we chose to use the
QuickDASH score measured at the longest follow-up in-
terval rather than at a single fixed follow-up interval;
however, neither approach can capture any fluctuations
in disability over time or with different patient trajec-
tories. We also did not investigate late secondary injury
or long-term recurrence of NTOS, but these will be the
subject of future investigation. Because of the recog-
nized potential for late recurrence after surgical treat-
ment for NTOS, follow-up examinations for $2 years
postoperatively have been suggested for analysis of late
outcomes.2,40
Finally, the present study represents just 1 cohort of
patients accrued during a 6-month period. The results
might, therefore, differ somewhat with a larger cohort.
It would be valuable to have a larger database of patients
with NTOS available, such as a national registry, for larger
scale studies in the future.2,41,42
CONCLUSIONS
The results of the present study have demonstrated
contemporary outcomes for physical therapy and surgi-
cal treatment in a well-studied cohort of patients with
NTOS, reinforcing that surgery can be effective when
physical therapy is insufficient, even with substantial
pretreatment disability. Substantial improvement in
symptoms can be expected for w90% of patients after
surgical treatment for NTOS and is reflected by
changes in the QuickDASH scores. Patients undergoing
surgical treatment experienced a greater extent of
improvement compared with those undergoing phys-
ical therapy alone. However, in our cohort, it was diffi-
cult to identify specific predictive factors for
individuals most likely to benefit from physical therapy
or from surgical treatment.
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